YU3901A - Oralni farmaceutski preparat sa fungicidnim dejstvom i postupak za njegovo pripremanje - Google Patents

Oralni farmaceutski preparat sa fungicidnim dejstvom i postupak za njegovo pripremanje

Info

Publication number
YU3901A
YU3901A YU3901A YU3901A YU3901A YU 3901 A YU3901 A YU 3901A YU 3901 A YU3901 A YU 3901A YU 3901 A YU3901 A YU 3901A YU 3901 A YU3901 A YU 3901A
Authority
YU
Yugoslavia
Prior art keywords
compound
preparation
activity
coat
antifungici
Prior art date
Application number
YU3901A
Other languages
English (en)
Inventor
Darder Carlos Picornell
Original Assignee
Liconsa Liberacion Controlada De Sustancias Activas S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8304581&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=YU3901(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Liconsa Liberacion Controlada De Sustancias Activas S.A. filed Critical Liconsa Liberacion Controlada De Sustancias Activas S.A.
Publication of YU3901A publication Critical patent/YU3901A/sh
Publication of RS50063B publication Critical patent/RS50063B/sr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Abstract

Sadrzi jedinjenje sa fungicidnim delovanjem kao aktivni sastojak, inertna jezgra i pravlaku, koja ukljucuje pomenuti aktivni sastojak, i naznacen je time sto pomenuta inertna jezgra imaju dimenzije cestica izmedju 50 i 600 µm, i sto se pomenuta prevlaka sastoji od samo jednog sloja dobijenog naprskavanjem na inertna jezgra u rastvoru koji sadrzi jedinjenje sa fungicidnim dejstvom, hidrofilni polimer i nejonski surfaktant. Postupak se sastoji od sprovodjenja prevlacenja inertnih jezgara u jednom sloju, pri cemu je dimenzija jezgara izmedju 50 i 600 µm, postupkom naprskavanja jednog rastvora sastavljenog od fungicidnog sredstva, hidrofilnog polimera u nejonskog surfaktanta, stalnom brzinom prevlacenja tokom celog postupka; i jednog jedinog koraka susenja prevlake u istoj aparaturi.
YUP-39/01A 1998-07-21 1999-07-20 Oralni farmaceutski preparat sa fungicidnim dejstvom i postupak za njegovo pripremanje RS50063B (sr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES009801539A ES2157731B1 (es) 1998-07-21 1998-07-21 Preparacion farmaceutica oral de un compuesto de actividad antifungica y procedimiento para su preparacion.
PCT/ES1999/000230 WO2000004881A1 (es) 1998-07-21 1999-07-20 Preparacion farmaceutica oral de un compuesto de actividad antifungica y procedimiento para su preparacion

Publications (2)

Publication Number Publication Date
YU3901A true YU3901A (sh) 2003-08-29
RS50063B RS50063B (sr) 2009-01-22

Family

ID=8304581

Country Status (31)

Country Link
US (1) US6737082B1 (sh)
EP (1) EP1103252B1 (sh)
JP (1) JP4190732B2 (sh)
KR (1) KR100572135B1 (sh)
AT (1) ATE234077T1 (sh)
AU (1) AU750730B2 (sh)
BG (1) BG65187B1 (sh)
BR (1) BR9912300A (sh)
CA (1) CA2337509C (sh)
CZ (1) CZ291938B6 (sh)
DE (1) DE69905905T2 (sh)
DK (1) DK1103252T3 (sh)
EE (1) EE04415B1 (sh)
ES (2) ES2157731B1 (sh)
HK (1) HK1037531A1 (sh)
HR (1) HRP20010128B1 (sh)
HU (1) HU228895B1 (sh)
IL (1) IL140910A (sh)
ME (1) MEP26708A (sh)
MX (1) MXPA01000681A (sh)
NO (1) NO320054B1 (sh)
NZ (1) NZ509886A (sh)
PL (1) PL194740B1 (sh)
PT (1) PT1103252E (sh)
RS (1) RS50063B (sh)
RU (1) RU2209628C2 (sh)
SK (1) SK283279B6 (sh)
TR (1) TR200100177T2 (sh)
UA (1) UA64009C2 (sh)
WO (1) WO2000004881A1 (sh)
ZA (1) ZA200101293B (sh)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0877563T3 (da) * 1996-01-31 2004-07-26 Univ South Alabama Levnedsmiddel- og vitaminpræparater, der indeholder den naturlige isomer af reducerede folater
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
KR100558239B1 (ko) 1999-12-23 2006-03-10 화이자 프로덕츠 인크. 증가된 약물 농도를 제공하는 제약학적 조성물
FR2842736B1 (fr) * 2002-07-26 2005-07-22 Flamel Tech Sa Formulation pharmaceutique orale sous forme d'une pluralite de microcapsules permettant la liberation prolongee de principe(s) actif(s) peu soluble(s)
US20040115287A1 (en) * 2002-12-17 2004-06-17 Lipocine, Inc. Hydrophobic active agent compositions and methods
DE60312635T3 (de) * 2003-01-14 2013-05-08 Cimex Pharma Ag Zusammensetzung in Form eines festen Dispersion enthaltend Itraconazol und ein hydrophilisches Polymer mit einer verbesserten Bioverfügbarkeit
DE60312636T3 (de) * 2003-01-14 2014-12-24 Acino Pharma Ag Bioaequivalente Zusammensetzung in der Form einer festen Dispersion enthaltend Itraconazol und ein hydrophiles Polymer
FR2852607B1 (fr) * 2003-03-20 2006-07-14 Procede de fabrication de microspheres de sucre de petite taille, les microspheres susceptibles d'etre obtenues par ce procede et leurs applications
FR2857591B1 (fr) * 2003-07-17 2007-11-02 Ethypharm Sa Particules comprenant un principe actif sous forme de co-precipite
EP1648467B1 (en) 2003-07-17 2018-03-21 Janssen Sciences Ireland UC Process for preparing particles containing an antiviral
FR2883179B1 (fr) 2005-03-18 2009-04-17 Ethypharm Sa Comprime enrobe
AU2006283040B2 (en) 2005-08-22 2011-08-25 The Johns Hopkins University Hedgehog pathway antagonists to treat disease
CN101283984B (zh) * 2007-04-12 2010-05-26 永胜药品工业股份有限公司 高生物使用率的经杀真菌剂和聚合物涂覆的核心微粒状物
US11304960B2 (en) 2009-01-08 2022-04-19 Chandrashekar Giliyar Steroidal compositions
EP2542222A2 (de) * 2010-03-05 2013-01-09 Basf Se Schmelzüberzogene arzneiformen
US9358241B2 (en) 2010-11-30 2016-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US9034858B2 (en) 2010-11-30 2015-05-19 Lipocine Inc. High-strength testosterone undecanoate compositions
US20180153904A1 (en) 2010-11-30 2018-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US20120148675A1 (en) 2010-12-10 2012-06-14 Basawaraj Chickmath Testosterone undecanoate compositions
US20170246187A1 (en) 2014-08-28 2017-08-31 Lipocine Inc. (17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
US9498485B2 (en) 2014-08-28 2016-11-22 Lipocine Inc. Bioavailable solid state (17-β)-hydroxy-4-androsten-3-one esters
MA40982A (fr) * 2014-11-19 2017-09-26 Biogen Ma Inc Formulation de bille pharmaceutique comprenant du fumarate de diméthyle
WO2016189481A1 (en) * 2015-05-25 2016-12-01 Sun Pharmaceutical Industries Limited Once daily oral pharmaceutical composition of isotretinoin
AU2017310506B2 (en) 2016-08-11 2019-11-21 Dmk Pharmaceuticals Corporation Drug compositions
US11559530B2 (en) 2016-11-28 2023-01-24 Lipocine Inc. Oral testosterone undecanoate therapy
EP3720844A4 (en) 2017-12-08 2021-08-11 Adamis Pharmaceuticals Corporation MEDICINAL COMPOSITIONS
CN112313289A (zh) * 2018-04-27 2021-02-02 凸版印刷株式会社 缓释性复合颗粒、缓释性复合颗粒的制造方法、干燥粉体、以及壁纸
WO2023118082A1 (en) * 2021-12-22 2023-06-29 Palau Pharma, S.L.U. Multiparticulate albaconazole composition

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4218458A (en) * 1978-06-23 1980-08-19 Janssen Pharmaceutica, N.V. Heterocyclic derivatives of (4-aryloxy-methyl-1,3-dioxolan-2-yl)methyl-1H-imidazoles and 1H-1,2,4-triazoles
US4916134A (en) * 1987-03-25 1990-04-10 Janssen Pharmacuetica N.V. 4-[4-[4-[4-[[2-(2,4-difluorophenyl)-2-(1H-azolylmethyl)-1,3-dioxolan-4-yl]me]phenyl]-1-piperazinyl]phenyl]triazolones
IE61651B1 (en) * 1990-07-04 1994-11-16 Zambon Spa Programmed release oral solid pharmaceutical dosage form
PH30929A (en) * 1992-09-03 1997-12-23 Janssen Pharmaceutica Nv Beads having a core coated with an antifungal and a polymer.
US5567441A (en) * 1995-03-24 1996-10-22 Andrx Pharmaceuticals Inc. Diltiazem controlled release formulation
EP0904060B1 (en) * 1996-05-20 2003-12-10 Janssen Pharmaceutica N.V. Antifungal compositions with improved bioavailability
RU2207119C2 (ru) * 1996-05-24 2003-06-27 Шеринг Корпорейшн Противогрибковый состав с повышенной биодоступностью
CZ421498A3 (cs) * 1996-06-28 1999-06-16 Schering Corporation Orální prostředek obsahující triazolovou antifungální sloučeninu
DE19626924C2 (de) * 1996-07-04 1999-08-19 Epazon B V Gerät zur Bereitstellung eines Atemgases
EE03904B1 (et) * 1997-03-26 2002-12-16 Janssen Pharmaceutica N.V. Graanul, farmatseutiline doseerimisvorm, graanulite valmistamismeetod ja ravimiga kaetud graanulid

Also Published As

Publication number Publication date
AU750730B2 (en) 2002-07-25
RS50063B (sr) 2009-01-22
JP4190732B2 (ja) 2008-12-03
DE69905905D1 (de) 2003-04-17
HUP0103708A3 (en) 2002-07-29
ES2157731A1 (es) 2001-08-16
MEP26708A (en) 2010-06-10
KR100572135B1 (ko) 2006-04-19
RU2209628C2 (ru) 2003-08-10
PT1103252E (pt) 2003-07-31
BG65187B1 (bg) 2007-06-29
KR20010070990A (ko) 2001-07-28
CA2337509A1 (en) 2000-02-03
CZ2001175A3 (en) 2001-05-16
IL140910A0 (en) 2002-02-10
DE69905905T2 (de) 2004-03-04
ATE234077T1 (de) 2003-03-15
EE200100041A (et) 2002-06-17
MXPA01000681A (es) 2002-04-24
HRP20010128A2 (en) 2002-12-31
ZA200101293B (en) 2001-08-21
PL194740B1 (pl) 2007-06-29
NO320054B1 (no) 2005-10-17
HK1037531A1 (en) 2002-02-15
TR200100177T2 (tr) 2001-07-23
HUP0103708A2 (hu) 2002-02-28
HU228895B1 (en) 2013-06-28
WO2000004881A1 (es) 2000-02-03
SK283279B6 (sk) 2003-05-02
SK862001A3 (en) 2001-08-06
JP2002521323A (ja) 2002-07-16
NO20010289D0 (no) 2001-01-17
DK1103252T3 (da) 2003-07-14
CA2337509C (en) 2005-12-27
CZ291938B6 (cs) 2003-06-18
EP1103252B1 (en) 2003-03-12
HRP20010128B1 (en) 2003-12-31
ES2157731B1 (es) 2002-05-01
EP1103252A1 (en) 2001-05-30
UA64009C2 (en) 2004-02-16
ES2194480T3 (es) 2003-11-16
BR9912300A (pt) 2001-04-17
US6737082B1 (en) 2004-05-18
NZ509886A (en) 2002-09-27
BG105282A (en) 2001-11-30
NO20010289L (no) 2001-03-07
AU4782199A (en) 2000-02-14
EE04415B1 (et) 2005-02-15
PL345625A1 (en) 2002-01-02
IL140910A (en) 2004-03-28

Similar Documents

Publication Publication Date Title
YU3901A (sh) Oralni farmaceutski preparat sa fungicidnim dejstvom i postupak za njegovo pripremanje
CA2322875A1 (en) A coated chewing gum, a method for preparation thereof and the use of one or more active substance(s) in solid form
CA2281420A1 (en) Preparation of pharmaceutically-active granules
AU3100700A (en) Antibiotic hydrophilic polymer coating
EP0351760A3 (en) Feed additive for ruminants
CA2348398A1 (en) Water-soluble coating agents bearing initiator groups and coating process
CA2446712A1 (en) System for osmotic delivery of pharmaceutically active agents
DE69431807T2 (de) Teilchenförmige synthetische Träger sowie Verfahren zu deren Herstellung
DE59507193D1 (de) VERFAHREN ZU hERSTELLUNG EINER MANTELTABLETTE MIT SPITZEM KERN
EP1002810A4 (en) POLYMER EMULSION AND METHOD FOR THE PRODUCTION THEREOF
FR2774288B1 (fr) Microgranules d'omeprazole gastroproteges, procede d'obtention et preparations pharmaceutiques
HK1063017A1 (en) Microgranules based on active principle and methodfor making same
DE69100670D1 (de) Eine Suspension hydratisierter Spheroide einer hydrophilen Lipidsubstanz enthaltendes wässriges kosmetisches bzw. dermopharmazeutisches Mittel.
AU1470195A (en) Nanoparticles containing an active substance and a ketalizedpolytartramidic acid, process for their preparation, and use thereof
EP0998944A3 (en) Enteric coated formulation of a benzimidazole derivative and method for preparation thereof
AU5320998A (en) Microparticles containing active substances, agents containing the same, their use in ultrasound-controlled releasing of active substances as well as the method for their production
AU692030B2 (en) Hydantoin derivatives, process for producing the same and herbicides comprising the same as active ingredients
Roders Application of coating of the die casting dies
TW259867B (en) Method for manufacturing magnetic recording medium